Lv31
280 积分 2023-05-25 加入
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
13天前
已完结
N6-methyladenosine reader IGF2BP2 in T-cell lymphoma
18天前
已完结
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
24天前
已完结
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial
24天前
已完结
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
26天前
已完结
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53 -Mutated Diffuse Large B-Cell Lymphoma
1个月前
已完结
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myeloma
1个月前
已完结
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study
1个月前
已完结
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma
2个月前
已完结
Prognostic stratification in DLBCL patients with aberrant MYC gene
2个月前
已完结
皖公网安备34019202002308
